Maria Orietta Borghi

Best Publications

• Pathogenesis of antiphospholipid syndrome: understanding the antibodies

  Pier Luigi Meroni;M. Orietta Borghi;Elena Raschi;Francesco Tedesco

  696
  Citations

• Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies

  Elena Raschi;Cinzia Testoni;Daniela Bosisio;Maria O. Borghi

  444
  Citations

• Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms.

  Silvia S. Pierangeli;Pojen P. Chen;Elena Raschi;Silvia Scurati

  312
  Citations

• Relationship between anti-phospholipid and anti-endothelial cell antibodies III: beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules.

  N Del Papa;L Guidali;L Spatola;P Bonara

  245
  Citations

• Toll‐like receptor and antiphospholipid mediated thrombosis: in vivo studies

  Silvia S. Pierangeli;Mariano E. Vega-Ostertag;Elena Raschi;Xiaowei Liu

  229
  Citations

• Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.

  Carlo Chizzolini;Elena Raschi;Roger Michel Rezzonico;Cinzia Testoni

  197
  Citations

• Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus

  Nicoletta Ronda;Elda Favari;Maria Orietta Borghi;Francesca Ingegnoli

  180
  Citations

• Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome.

  Maria Orietta Borghi;Asmaa Beltagy;Emirena Garrafa;Daniele Curreli

  174
  Citations

• Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases?

  Pier Luigi Meroni;Maria Orietta Borghi;Claudia Grossi;Cecilia Beatrice Chighizola

  156
  Citations

• Complement activation and endothelial perturbation parallel COVID-19 severity and activity.

  Massimo Cugno;Pier Luigi Meroni;Roberta Gualtierotti;Samantha Griffini

  155
  Citations

• A non–complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome

  Chiara Agostinis;Paolo Durigutto;Daniele Sblattero;Maria O. Borghi

  154
  Citations

• Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases.

  Xavier Bossuyt;Ellen De Langhe;Maria Orietta Borghi;Pier Luigi Meroni

  151
  Citations

• Association of Pyoderma Gangrenosum, Acne, and Suppurative Hidradenitis (PASH) Shares Genetic and Cytokine Profiles With Other Autoinflammatory Diseases

  Angelo V. Marzano;Isabella Ceccherini;Marco Gattorno;Daniele Fanoni

  150
  Citations

• Endothelial cell activation by antiphospholipid antibodies

  P.L Meroni;E Raschi;C Testoni;M.O Borghi

  147
  Citations

• Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.

  T Avcin;R Cimaz;F Falcini;F Zulian

  146
  Citations

• Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis.

  G. Ferraro;P. L. Meroni;A. Tincani;A. Sinico

  146
  Citations

• In vivo distribution of β2 glycoprotein I under various pathophysiologic conditions.

  Chiara Agostinis;Stefania Biffi;Chiara Garrovo;Paolo Durigutto

  144
  Citations

• Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation

  Massimo Cugno;Daniela Mari;Pier Luigi Meroni;Edoardo Gronda

  136
  Citations

• Newly Identified Antiatherosclerotic Activity of Methotrexate and Adalimumab: Complementary Effects on Lipoprotein Function and Macrophage Cholesterol Metabolism

  Nicoletta Ronda;Daniela Greco;Maria Pia Adorni;Francesca Zimetti

  135
  Citations

• Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.

  Laura Andreoli;Cecilia B. Chighizola;Cecilia Nalli;Maria Gerosa

  129
  Citations